Pyrazinamide

Chemical formula: Câ‚…Hâ‚…N₃O  Molecular mass: 123.113 g/mol  PubChem compound: 1046

Therapeutic indications

Pyrazinamide is indicated for:

Tuberculosis caused by Mycobacterium tuberculosis

Population group: only adults (18 years old or older)

Pyrazinamide is indicated in patients with active tuberculosis caused by Mycobacterium tuberculosis. Pyrazinamide should only be given in combination with other antituberculous agents.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Tuberculosis caused by Mycobacterium tuberculosis

Population group: only children (1 year - 12 years old) , adolescents (12 years - 18 years old)

Pyrazinamide is indicated in patients with active tuberculosis caused by Mycobacterium tuberculosis. Pyrazinamide should only be given in combination with other antituberculous agents.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Pyrazinamide is contraindicated in the following cases:

Gouty arthritis

Articular gout

Hypersensitivity to pyrazinamide

Pyrazinamide allergy

Hyperuricemia

Hyperuricemia

Acute porphyria

Acute intermittent porphyria

Hepatic disease

at least one of
Hepatopathy
Hepatic insufficiency

Lactation

Lactation

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.